Learning Objectives:

  1. Understand clinical presentation of familial amyotrophic lateral sclerosis
  2. Understand delivery of antisense oligonucleotide therapeutics
  3. Understand measures of efficacy in ALS clinical trials
Session date: 
02/17/2022 - 7:30am to 8:30am CST
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. TImothy Miller